Skip to main content
Journal cover image

Breast Cancer Risk-Reducing Medications.

Publication ,  Journal Article
Graham, D; DiNome, ML; Ganz, PA
Published in: JAMA
July 21, 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

July 21, 2020

Volume

324

Issue

3

Start / End Page

310

Location

United States

Related Subject Headings

  • Tamoxifen
  • Selective Estrogen Receptor Modulators
  • Risk Factors
  • Raloxifene Hydrochloride
  • Humans
  • General & Internal Medicine
  • Female
  • Breast Neoplasms
  • Aromatase Inhibitors
  • Anticarcinogenic Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Graham, D., DiNome, M. L., & Ganz, P. A. (2020). Breast Cancer Risk-Reducing Medications. JAMA, 324(3), 310. https://doi.org/10.1001/jama.2020.11784
Graham, Danielle, Maggie L. DiNome, and Patricia A. Ganz. “Breast Cancer Risk-Reducing Medications.JAMA 324, no. 3 (July 21, 2020): 310. https://doi.org/10.1001/jama.2020.11784.
Graham D, DiNome ML, Ganz PA. Breast Cancer Risk-Reducing Medications. JAMA. 2020 Jul 21;324(3):310.
Graham, Danielle, et al. “Breast Cancer Risk-Reducing Medications.JAMA, vol. 324, no. 3, July 2020, p. 310. Pubmed, doi:10.1001/jama.2020.11784.
Graham D, DiNome ML, Ganz PA. Breast Cancer Risk-Reducing Medications. JAMA. 2020 Jul 21;324(3):310.
Journal cover image

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

July 21, 2020

Volume

324

Issue

3

Start / End Page

310

Location

United States

Related Subject Headings

  • Tamoxifen
  • Selective Estrogen Receptor Modulators
  • Risk Factors
  • Raloxifene Hydrochloride
  • Humans
  • General & Internal Medicine
  • Female
  • Breast Neoplasms
  • Aromatase Inhibitors
  • Anticarcinogenic Agents